EBITDA for Eli Lilly (LLY)
According to Eli Lilly's latest reported financial statements, the company's current EBITDA (TTM) is $27.94B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
LLY
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$27.94B
YoY change
+83.5%
5Y CAGR
+25.7%
Peak year (2025)
$27.94B
Cumulative EBITDA
$208.96B
EBITDA history chart for Eli Lilly (LLY) from 1985 to 2025
EBITDA history table for Eli Lilly (LLY) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $27.94B | +83.5% | ||
| 2024 | $15.23B | +77.7% | ||
| 2023 | $8.57B | -1.1% | ||
| 2022 | $8.66B | +7.7% | ||
| 2021 | $8.04B | -9.8% | ||
| 2020 | $8.91B | +29.2% | ||
| 2019 | $6.90B | +24.7% | ||
| 2018 | $5.53B | +35.0% | ||
| 2017 | $4.10B | -19.0% | ||
| 2016 | $5.06B | +15.5% | ||
| 2015 | $4.38B | -3.3% | ||
| 2014 | $4.53B | -39.6% | ||
| 2013 | $7.50B | +6.3% | ||
| 2012 | $7.05B | +2.0% | ||
| 2011 | $6.91B | -14.1% | ||
| 2010 | $8.04B | +16.2% | ||
| 2009 | $6.92B | +15874.4% | ||
| 2008 | $43.30M | -99.3% | ||
| 2007 | $5.85B | +18.7% | ||
| 2006 | $4.93B | +12.6% | ||
| 2005 | $4.38B | +2.8% | ||
| 2004 | $4.26B | +5.1% | ||
| 2003 | $4.05B | +6.0% | ||
| 2002 | $3.82B | -8.7% | ||
| 2001 | $4.18B | +4.7% | ||
| 2000 | $4.00B | +5.1% | ||
| 1999 | $3.80B | +14.7% | ||
| 1998 | $3.31B | +12.4% | ||
| 1997 | $2.95B | +13.9% | ||
| 1996 | $2.59B | +2.1% | ||
| 1995 | $2.54B | +13.8% | ||
| 1994 | $2.23B | +111.9% | ||
| 1993 | $1.05B | -31.0% | ||
| 1992 | $1.52B | -26.3% | ||
| 1991 | $2.07B | +15.7% | ||
| 1990 | $1.79B | +28.2% | ||
| 1989 | $1.39B | +11.5% | ||
| 1988 | $1.25B | +60.5% | ||
| 1987 | $779.30M | -24.9% | ||
| 1986 | $1.04B | +15.3% | ||
| 1985 | $900.60M | — |
EBITDA values are taken from Eli Lilly's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Eli Lilly (LLY) EBITDA is $27.94B – surged 83.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Eli Lilly EBITDA compounded at +25.7% per year, sustaining 2 straight years of year-over-year growth.
2025 marks the peak EBITDA at $27.94B, with the historical low of $43.30M recorded in 2008.
Eli Lilly (LLY) sits 3rd of 8 Healthcare peers we track on this metric, against a peer median of $21.44B.
Eli Lilly EBITDA by Year
Eli Lilly EBITDA 2025: $27.94B
Eli Lilly EBITDA in 2025 was $27.94B, surged 83.5% from 2024. This figure represents the highest annual value in the available history.
Eli Lilly EBITDA 2024: $15.23B
Eli Lilly EBITDA in 2024 was $15.23B, surged 77.7% from 2023.
Eli Lilly EBITDA 2023: $8.57B
Eli Lilly EBITDA in 2023 was $8.57B, edged down 1.1% below 2022.
Eli Lilly EBITDA 2022: $8.66B
Eli Lilly EBITDA in 2022 was $8.66B, grew 7.7% from 2021.
Eli Lilly EBITDA 2021: $8.04B
Eli Lilly EBITDA in 2021 was $8.04B.
See more financial history for Eli Lilly (LLY).
Sector peers — EBITDA
Companies in the same sector as Eli Lilly, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $11.47B | Healthcare |
Frequently asked questions
What is Eli Lilly's EBITDA?
- Latest reported EBITDA for Eli Lilly (LLY) is $27.94B (period ending December 31, 2025).
How has Eli Lilly EBITDA changed year-over-year?
- Eli Lilly (LLY) EBITDA changed +83.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Eli Lilly EBITDA?
- Eli Lilly (LLY) EBITDA compound annual growth rate is +25.7% over the most recent 5 years available.
When did Eli Lilly EBITDA hit its highest annual value?
- Eli Lilly EBITDA reached its highest annual value of $27.94B in 2025.
What was Eli Lilly EBITDA in 2024?
- Eli Lilly (LLY) EBITDA in 2024 was $15.23B.
What was Eli Lilly EBITDA in 2025?
- Eli Lilly (LLY) EBITDA in 2025 was $27.94B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LLY Overview
Company profile, financial tools, and key metrics
LLY Revenue Counter
Earns $2,067 every second. See per minute, hour, and day.
LLY Earnings Counter
Earns $654.44 per second net profit. See per minute, hour, and day.
LLY Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
LLY What If Invested
What if you had invested $1,000? See historical returns from any date.
LLY How It Makes Money
Discover visual breakdown of $65.18B in revenue — where it comes from and where it goes.
LLY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LLY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LLY Daily Price Character
Steady · 48.0% historical win rate (green days). Streaks & record days.
LLY Buybacks
0.43% TTM buyback yield. Shareholder yield & SBC comparison.
LLY Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LLY Dividend Profile
Yield: 0.73%. Safety: 8/8. See full history.
LLY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LLY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.